Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900768 | 0.86 | DRD1 (0.33) | LMNAMEN1MAPTKMT2A | |
| SCHEMBL28987498 | 0.80 | — | — | |
| SCHEMBL16951401 | 0.78 | ALDH1A1 (0.33) | LMNAKMT2AGAA | |
| SCHEMBL900739 | 0.78 | — | — | |
| SCHEMBL1067020 | 0.77 | MAPT (0.41) | LMNAMEN1MAPTRAB9AKMT2A | |
| SCHEMBL1066949 | 0.77 | — | — | |
| SCHEMBL16956555 | 0.77 | ALOX15 (0.32) | — | |
| SCHEMBL1064063 | 0.77 | MEN1 (0.31) | LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5850517 | 0.77 | APP (0.33) | — | |
| SCHEMBL1068589 | 0.77 | ALOX15 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112204021-B | Novel heteroaryl triazoles and heteroaryl tetrazoles as pesticides | 拜耳公司 | 2024-05-28 | — | — | CN | claimed |
| EP-3784661-B1 | NOVEL HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2023-11-22 | — | — | EP | claimed |
| EP-3919486-B1 | NOVEL HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2023-06-07 | — | — | EP | claimed |
| CN-114423748-A | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2022-04-29 | — | — | CN | claimed |
| CN-112204021-A | Novel heteroaryltriazole and heteroaryltetrazole compounds as pesticides | 拜耳公司 | 2021-01-08 | — | — | CN | claimed |
| CN-101407453-A | A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide | ASTRAZENECA AB (SE) | 2009-04-15 | — | — | CN | claimed |
| CN-1886359-A | Process for resolving optionally substituted mandelic acids by salt formation with chiral base cyclic amides | ASTRAZENECA AB (SE) | 2006-12-27 | — | — | CN | claimed |
| CN-112204021-B | Novel heteroaryl triazoles and heteroaryl tetrazoles as pesticides | 拜耳公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114423748-A | Novel heteroaryl triazole compounds as pesticides | 拜耳公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-114127062-A | Thiadiazolyl derivatives as inhibitors of DNA polymerase Theta | 伊迪亚生物科学有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-107690434-B | Fused tricyclic imidazopyrazine derivatives as modulators of TNF activity | UCB生物制药私人有限公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-112204021-A | Novel heteroaryltriazole and heteroaryltetrazole compounds as pesticides | 拜耳公司 | 2021-01-08 | — | — | CN | disclosed |
| EP-3303337-B1 | FUSED TRICYCLIC IMIDAZO PYRAZINES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2020-05-27 | — | — | EP | disclosed |
| US-20100311581-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | BASF SE (DE) | 2010-12-09 | — | — | US | disclosed |
| CN-101902914-A | Azolylmethyloxiranes, use thereof and compositions comprising same | BASF SE | 2010-12-01 | — | — | CN | disclosed |
| US-20100273651-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
| CN-101407453-A | A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide | ASTRAZENECA AB (SE) | 2009-04-15 | — | — | CN | disclosed |
| CN-100448834-C | Process for resolving optionally substituted mandelic acids by salt formation with chiral base cyclic amides | ASTRAZENECA AB (SE) | 2009-01-07 | — | — | CN | disclosed |
| CN-101180256-A | Method for kinetic resolution of (substituted) (R) -or (S) -mandelic acids | ASTRAZENECA AB ASTRAZENECA UK (SE) | 2008-05-14 | — | — | CN | disclosed |
| CN-1886359-A | Process for resolving optionally substituted mandelic acids by salt formation with chiral base cyclic amides | ASTRAZENECA AB (SE) | 2006-12-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273651-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | XDH, SQOR, NOX5 | LMNA 4264/4885MEN1 1585/4885MAPT 3863/4885 |
| US-20100311581-A1 | Azolylmethyloxiranes, use Thereof and Agents Containing the Same | XDH, DAO, DHODH | LMNA 4292/4885MEN1 1626/4885MAPT 3819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.